
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1010 | 999 | 1061 | 1272 | 1606 | 2489 |
Fund Return | 0.99% | -0.1% | 6.1% | 8.35% | 9.94% | 9.55% |
Place in category | 1642 | 1666 | 1769 | 1254 | 982 | 141 |
% in Category | 87 | 87 | 97 | 81 | 75 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer International Equity Fund Cla | 8.12B | 8.50 | 9.82 | 6.77 | ||
Mawer US Equity A | 4.31B | 3.93 | 12.37 | 12.22 | ||
Mawer Canadian Equity A | 3.67B | 3.21 | 8.53 | 7.61 | ||
Mawer Global Small Cap A | 2.82B | 2.15 | 1.33 | 6.28 | ||
Mawer Tax Effective Balanced Fund C | 1.61B | 3.39 | 6.20 | 5.95 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 17.07B | -0.93 | 23.49 | - | ||
Capital Group Glbal Equity Fd F CAD | 14B | 2.07 | 11.83 | 10.97 | ||
Capital Group Glbal Equity Fd A CAD | 14B | 1.89 | 10.61 | 9.74 | ||
Capital Group Glbal Equity Fd D CAD | 14B | 2.03 | 11.47 | 10.50 | ||
EdgePoint Glbl Port non HST Sr A | 12.92B | 5.94 | 8.84 | 7.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.24 | 91.98 | -0.80% | |
Marsh McLennan | US5717481023 | 4.43 | 233.37 | +0.34% | |
Alphabet C | US02079K1079 | 4.14 | 165.05 | -0.74% | |
Microsoft | US5949181045 | 4.14 | 386.84 | -0.25% | |
UnitedHealth | US91324P1021 | 3.93 | 511.30 | +1.61% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review